Jeffords James M
Senate Environment and Public Works Committee, United States Senate, USA.
Health Aff (Millwood). 2004 Jan-Jun;Suppl Web Exclusives:W4-253-5. doi: 10.1377/hlthaff.w4.253.
Between 1997 and 2001 spending on direct-to-consumer (DTC) drug advertising more than doubled. Opinions differ as to whether and to what extent DTC advertising benefits the doctor-patient relationship. Some analysts argue that the current regulatory regime is sufficient, others advocate a stricter enforcement, and still others promote an outright ban. An alternative may be to use the purchasing power of the federal government to require the inclusion of comparative quality data, thus creating a basis for more informed consumer choice. This approach could create incentives for the pharmaceutical industry to adjust spending on DTC advertising while avoiding "big government" interference with commercial free speech.
1997年至2001年间，直接面向消费者（DTC）的药品广告支出增加了一倍多。对于DTC广告是否以及在多大程度上有利于医患关系，存在不同意见。一些分析人士认为，当前的监管制度已经足够，另一些人主张加强执法，还有一些人则提倡彻底禁止。另一种选择可能是利用联邦政府的购买力，要求纳入比较质量数据，从而为消费者做出更明智的选择创造基础。这种方法可以促使制药行业调整DTC广告支出，同时避免“大政府”对商业言论自由的干涉。
